Mankind Pharma Ltd share price logo

Mankind Pharma Share Price

NSE: MANKIND

BSE: 543904

Mid Cap

Healthcare Sector

₹2244.40

+30.50

(+1.38%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Mankind Pharma Stock Performance

as on January 14, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹2,207.10
    ₹2,252.20
    downward going graph

    1.66%

    Downside

    0.35%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹2,090.00
    ₹2,754.70
    downward going graph

    6.88%

    Downside

    22.74%

    Upside

    downward going graph

Mankind Pharma share price movements today

Previous Close
₹2,213.90
Open
₹2,224.00
Volume
2.55L
Upper Circuit
₹2,435.20
Lower Circuit
₹1,992.60
Day's Low - High
₹2,207.10 - ₹2,252.20
52 Week Low - High
₹2,090.00 - ₹2,754.70

Mankind Pharma Historical Returns

1 Month Return
+ 4.82 %
3 Month Return
-8.23 %
1 Year Return
-13.54 %
3 Year Return
+ 57.8 %
5 Year Return
+ 57.8 %

Mankind Pharma Fundamentals

as on January 14, 2026 at 4:01 pm IST

Market Cap

₹92,649.97 Cr

Return on Equity (ROE)

13.89

PE Ratio (TTM)

52.61

Return on capital employed (ROCE)

14.88

Industry PE ratio

41.59

Beta (LTM)

0.69

P/B Ratio

6.83

Dividend Yield

0

PEG Ratio

-5.19

Quarterly Earnings Growth YOY

-21.05

EPS (TTM)

48.74

Sector

Pharmaceuticals

Book Value

347.37

Technical Analysis

Bullish

View Technical Analysis

Mankind Pharma Stock Valuation

as on January 14, 2026 at 4:01 pm IST

Mankind Pharma in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Industry (41.59x)

January 14, 2026

Today (52.61x)

January 14, 2026

Highest (58.15x)

October 7, 2025

LowHigh

Today’s Price to Earnings Ratio: 52.61x

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mankind Pharma Ltd image
Mankind Pharma Ltd
BUY92,649.9711.56%0.692,01112,207
Anthem Biosciences Ltd image
Anthem Biosciences Ltd
BUY34,977.07-2.95%0.534511,844
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY40,569.3611.53%0.569273,749
Abbott India Ltd image
Abbott India Ltd
BUY59,245.0017.18%0.001,4146,445
Laurus Labs Ltd image
Laurus Labs Ltd
HOLD58,871.3638.94%0.713545,553
See all

Analyst Recommendation on Mankind Pharma Stock

Based on 18 analysts

BUY

77.78%

Buy

11.11%

Hold

11.11%

Sell

Based on 18 analysts, 77.78% of analysts recommend a 'BUY' rating for Mankind Pharma. Average target price of ₹2631.17

Source: S&P Global Market Intelligence

Mankind Pharma Share Price Target

Get share price movements and forecasts by analysts on Mankind Pharma.

What analysts predicted

17.23%UPSIDE

Target Price

₹2631.17

Current Price

₹2244.4

Analyzed by

18 Analysts

High

₹3110

Target

₹2631.17

Low

₹2150

Mankind Pharma target price ₹2631.17, a slight upside of 17.23% compared to current price of ₹2244.4. According to 18 analysts rating.

Source: S&P Global Market Intelligence

Mankind Pharma Stock’s Investor Sentiment and Interest

Investment in Mankind Pharma Ltd Shares on INDmoney has grown by 13.07% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:13.07% versus previous 30 day period

Search interest for Mankind Pharma Ltd Stock has increased by 115% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:115% versus previous 30 day period

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
2,052.67
2,578.62
2,708.1
2,606.95
2,422.24
2,867.85
3,061.43
3,198.79
3,079.37
3,570.35
3,697.16
Other Income
50.28
63.35
63.45
74.73
94.56
107.9
111.63
87.09
253.65
83.05
94.19
Total Income
2,102.95
2,641.97
2,771.55
2,681.68
2,516.8
2,975.75
3,173.06
3,285.88
3,333.02
3,653.4
3,791.35
Expenses
1,635.99
1,923.81
2,025.45
2,000.45
1,836.27
2,196.29
2,216.61
2,382.8
2,400.52
2,723.58
2,775.83
Operating Profit
416.68
654.81
682.65
606.5
585.97
671.56
844.82
815.99
678.85
846.77
921.33
Operating Profit Margin %
20.3%
25.39%
25.21%
23.26%
24.19%
23.42%
27.6%
25.51%
22.05%
23.72%
24.92%
Profit Before Interest, Tax and Depreciation
466.96
718.16
746.1
681.23
680.53
779.46
956.45
903.08
932.5
929.82
1,015.52
Interest
5.16
6.34
8.62
9.19
9.17
10.84
7.1
220.93
190.54
170.65
169.68
Depreciation
84.52
87.35
96.49
109.72
99.78
102.69
100.49
187.17
230.87
218.68
221.82
Profit Before Tax
377.28
624.47
640.99
562.32
571.58
665.93
848.86
494.98
511.09
540.49
624.02
Tax Paid
83.59
130.28
129.81
102.51
94.99
122.86
189.98
110.46
86.44
95.87
103.84
Profit After Tax
293.7
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
Total Net profit including share of profit / Loss from associate company
293.7
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
EPS
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
Actual EPS
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
Adjusted EPS
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
Diluted EPS
7.13
12.14
12.49
11.31
11.74
13.37
16.28
9.44
10.18
10.6
12.38

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
Interest
21.97
20.15
58.61
44.47
32.75
429.41
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
EPS
26.36
32.28
35.78
32
47.75
49.28
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87

Mankind Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
May 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
76.5%
76.5%
76.5%
76.5%
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
72.66%
DII
2.64%
2.64%
4.64%
4.39%
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
13.25%
FII
0%
0%
0%
0%
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
11.34%
Public
18.25%
18.25%
14.68%
14.76%
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
2.75%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
41,28,05,072
Total Shareholders
4,02,322
4,02,322
1,31,918
1,34,731
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347
1,77,539

Mutual Funds that own Mankind Pharma Stock

Check out the Mutual Funds with significant holdings in Mankind Pharma.

Mankind Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Mankind Pharma.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit fell -21.72% since last year same period to ₹511.51Cr in the Q2 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 16.7% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Mankind Pharma Ltd Dividends July,2025

    In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.04%.

    Read More about Dividends

Indices Featuring Mankind Pharma Stock

Check stock indices that include Mankind Pharma.

Nifty Midcap Sel

₹13,705.90

0.42 (▲56.65%)

S&P BSE Largecap

₹9,871.31

-0.07 (▲6.93%)

BSE Healthcare

₹43,362.66

-0.09 (▲40.19%)

Nifty LargeMidcap 250

₹16,600.35

0.03 (▲4.90%)

S&P BSE 250 LargeMidCap

₹11,014.23

-0.02 (▲2.42%)

Nifty Midcap 150

₹21,965.45

0.21 (▲46.75%)

BSE 500

₹36,805.06

0.00 (▲1.15%)

Nifty 200

₹14,309.40

-0.07 (▲10.45%)

Nifty MidSmallcap 400

₹19,865.10

0.30 (▲60.40%)

Nifty Healthcare

₹14,555.55

-0.25 (▲36.25%)

NIFTY PHARMA

₹22,505.40

-0.25 (▲56.90%)

BSE 200

₹11,612.50

-0.07 (▲8.32%)

Nifty Midcap 100

₹59,770.50

0.29 (▲172.70%)

Nifty Midcap 50

₹17,054.25

0.12 (▲20.25%)

S&P BSE 100 LargeCap TMC

₹9,483.65

-0.11 (▲9.98%)

Nifty 500

₹23,475.85

-0.02 (▲4.80%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.34% to 7.78% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MANKIND stock has moved up by 4.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 380.23 Cr → 511.51 Cr (in ₹), with an average increase of 9.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 7 quarters, 2.51K Cr → 3.79K Cr (in ₹), with an average increase of 6.5% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.68% to 72.67% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 2.75% to 2.57% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 13.07% to 12.84% in Sep 2025 quarter

Mankind Pharma Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 27 Jan ₹2300 Call
January 27, 2026
₹2300
₹16.3
2.2
15.6%
MANKIND 27 Jan ₹2200 Call
January 27, 2026
₹2200
₹61.35
10.05
19.59%
MANKIND 27 Jan ₹2900 Call
January 27, 2026
₹2900
₹2.75
0.6
27.91%
MANKIND 27 Jan ₹2250 Call
January 27, 2026
₹2250
₹33.3
5.5
19.78%

Mankind Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 27 Jan Fut
January 27, 2026
-
₹2242
27.9
1.26%
MANKIND 24 Feb Fut
February 24, 2026
-
₹2253
26.28
1.18%
MANKIND 30 Mar Fut
March 30, 2026
-
₹2270
26.47
1.18%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹3,697.16Cr as on September 2025 (Q2 FY26)
Net Profit: ₹520.18Cr as on September 2025 (Q2 FY26)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma share price today?

Mankind Pharma share price today stands at ₹2244.4 as on at the close of the market. Mankind Pharma share today touched a day high of ₹2252.2 and a low of ₹2207.1.

What is the 52 week high and 52 week low range for Mankind Pharma share?

Mankind Pharma touched a 52 week high of ₹2754.7 and a 52 week low of ₹2090. Mankind Pharma share price today i.e. is closed at ₹2244.4, which is -18.52% down from its 52 week high and 7.39% up from its 52 week low.

What is Mankind Pharma's market capitalisation today?

Mankind Pharma market capitalisation is ₹92,649.97 Cr as on .

How to buy Mankind Pharma shares?

To buy Mankind Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma trading volume today?

Mankind Pharma trading volume is 2.55L as on . This means that 2.55L shares of Mankind Pharma were bought and sold on the stock market during today's trading session.